BDBM14486 (2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicyclo[4.3.0]nona-1,3,5,8-tetraen-7-yl)-5-methyl-oxolane-3,4-diol::(2R,3R,4S,5R)-2-{4-amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-5-methyloxolane-3,4-diol::5-IT::5-Iodo-5-deoxytubercidin::7-(5-deoxy-beta-D-ribofuranosyl)-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-4-amine::CHEMBL66280

SMILES C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(I)c2c(N)ncnc12

InChI Key InChIKey=NTXUAWGNGBSCRS-TZQXKBMNSA-N

Data  10 IC50

PDB links: 1 PDB ID matches this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 14486   

TargetAdenosine kinase(Rattus norvegicus (rat))
Abbott Laboratories

LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  0.900nMpH: 7.5 T: 2°CAssay Description:ADK activity was monitored by a radiochemical assay, which measures the conversion of radioactive Ado ([U-14C] adenosine or [2-3H] adenosine) to AMP ...More data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  9nMAssay Description:Inhibition of recombinant human adenosine kinaseMore data for this Ligand-Target Pair
TargetAdenosine kinase(Rattus norvegicus (rat))
Abbott Laboratories

LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  1.60nMAssay Description:In vitro inhibition of Adenosine kinase (AK)More data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  22.8nMAssay Description:Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.More data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  9nMAssay Description:Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMPMore data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  9nMAssay Description:Inhibition of human adenosine kinase activityMore data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  9nMAssay Description:Inhibitory concentration against human recombinant adenosine kinase using [14C]-AMP as radioligandMore data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  8.91nMAssay Description:Concentration required for 50% inhibition of the adenosine kinase (AK) activity.More data for this Ligand-Target Pair
TargetAdenosine kinase(Homo sapiens (Human))
Metabasis Therapeutics

Curated by ChEMBL
LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  9.00E+6nMAssay Description:Inhibition of adenosine kinase (unknown origin)More data for this Ligand-Target Pair
TargetAdenosine kinase(Rattus norvegicus (rat))
Abbott Laboratories

LigandPNGBDBM14486((2R,3R,4S,5R)-2-(2-amino-9-iodo-3,5,7-triazabicycl...)
Affinity DataIC50:  1.60nMAssay Description:In vitro inhibition of Adenosine kinase of rat brain cytosol.More data for this Ligand-Target Pair